Julia G. Butchko - Aug 30, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Dev. & Tech. Officer
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Julia G. Butchko
Stock symbol: IMVT
Transactions as of: Aug 30, 2022
Transactions value $: -$3,195
Form type: 4
Date filed: 9/1/2022, 07:33 AM
Previous filing: Aug 19, 2022
Next filing: Sep 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	-$3.19K	-548	-0.14%	$5.83	393K	Aug 30, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Content

On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.